2LK4

Structural and mechanistic insights into the interaction between PAT Pyk2 and Paxillin LD motif

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D CBCA(CO)NH	0.5-1 mM [U-100% 13C; U-100% 15N] MES	90% H2O/10% D2O	7	6.2	ambient	305
2	3D HNCACB	0.5-1 mM [U-100% 13C; U-100% 15N] MES	90% H2O/10% D2O	7	6.2	ambient	305
3	3D HNCA	0.5-1 mM [U-100% 13C; U-100% 15N] MES	90% H2O/10% D2O	7	6.2	ambient	305
4	3D HCCH-TOCSY	0.5-1 mM [U-100% 13C; U-100% 15N] MES	90% H2O/10% D2O	7	6.2	ambient	305
5	3D 1H-15N NOESY	0.5-1 mM [U-100% 13C; U-100% 15N] MES	90% H2O/10% D2O	7	6.2	ambient	305
6	3D 1H-13C NOESY aliphatic	0.5-1 mM [U-100% 13C; U-100% 15N] MES	90% H2O/10% D2O	7	6.2	ambient	305
7	3D HNHA	0.5-1 mM [U-100% 13C; U-100% 15N] MES	90% H2O/10% D2O	7	6.2	ambient	305

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	Avance	600
2	Bruker	Avance	800

NMR Refinement
Method	Details	Software
distance geometry		CYANA

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (minimized average structure)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
2	refinement	CYANA		Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.